21-hydroxylase deficiency secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{AAM}} | {{CMG}} {{AE}} {{AAM}} | ||
==Overview== | ==Overview== | ||
Continued monitoring of hormone balance and careful readjustment of glucocorticoid dose is helpful in controlling fertility. | Continued monitoring of hormone balance and careful readjustment of [[glucocorticoid]] dose is helpful in controlling [[fertility]]. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
===Preventing hyperandrogenism and optimizing fertility=== | ===Preventing hyperandrogenism and optimizing fertility=== | ||
Continued monitoring of hormone balance and careful readjustment of glucocorticoid dose is helpful in controlling fertility, but as a group, women with CAH have a lower fertility rate than a comparable population. | Continued monitoring of hormone balance and careful readjustment of [[glucocorticoid]] dose is helpful in controlling [[fertility]], but as a group, women with CAH have a lower fertility rate than a comparable population. | ||
== References == | == References == |
Revision as of 16:54, 4 September 2015
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
21-hydroxylase deficiency secondary prevention On the Web |
American Roentgen Ray Society Images of 21-hydroxylase deficiency secondary prevention |
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
Risk calculators and risk factors for 21-hydroxylase deficiency secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
Continued monitoring of hormone balance and careful readjustment of glucocorticoid dose is helpful in controlling fertility.
Secondary Prevention
Preventing hyperandrogenism and optimizing fertility
Continued monitoring of hormone balance and careful readjustment of glucocorticoid dose is helpful in controlling fertility, but as a group, women with CAH have a lower fertility rate than a comparable population.